Bajaj Healthcare

29
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
339.80
-2.2 (-0.64%)
BSENSE

Feb 02

BSE+NSE Vol: 87.12 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024

Compare Profit and Loss Results of Bajaj Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
542.00
370.00
172.00
46.49%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
542.00
370.00
172.00
46.49%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
1.00
-21.00
-2,100.00%
Raw Materials Consumed
307.00
181.00
126.00
69.61%
Power & Fuel Cost
22.00
23.00
-1.00
-4.35%
Employee Cost
57.00
43.00
14.00
32.56%
Operating Expenses
63.00
3.00
60.00
2,000.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
16.00
-10.00
-62.50%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
2.00
4.00
200.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
460.00
289.00
171.00
59.17%
Operating Profit (PBDIT) excl Other Income
82.00
80.00
2.00
2.50%
Other Income
19.00
1.00
18.00
1,800.00%
Operating Profit (PBDIT)
101.00
82.00
19.00
23.17%
Interest
27.00
9.00
18.00
200.00%
Profit before Depriciation and Tax
73.00
72.00
1.00
1.39%
Depreciation
27.00
18.00
9.00
50.00%
Profit Before Taxation & Exceptional Items
46.00
54.00
-8.00
-14.81%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
54.00
-8.00
-14.81%
Provision for Tax
3.00
14.00
-11.00
-78.57%
Profit After Tax
42.00
39.00
3.00
7.69%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
267.00
206.00
61.00
29.61%
Profit Available for appropriations
310.00
246.00
64.00
26.02%
Appropriations
310.00
246.00
64.00
26.02%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
13.29
38.44
-25.15
-65.43%
Profit And Loss - Net Sales
Net Sales 542.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024

Profit And Loss - Interest
Interest 27.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 42.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024